Lupin Receives Final Approval for Quinapril Tablets (RedNova)
BALTIMORE, June 26 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Quinapril Tablets USP in 5 mg, 10 mg, 20 mg and 40 mg strengths.

Endo Receives FDA Approval For Opana(R) ER (oxymorphone HCl) Extended-Release And Opana(R) (oxymorphone HCl) Immediate (Medical News Today)
Endo Pharmaceuticals Inc., awholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (Nasdaq:ENDP), today announced that the U.S. Food and Drug Administration (FDA) hasgranted final approval of the company's New Drug Applications (NDAs) forits extended- release and immediate-release formulations of oxymorphonehydrochloride. [click link for full article]

Bioheart, Inc. To Receive Funds From a Grant Awarded By the State of Ohio to Further Develop Adult Stem Cell Therapies (RedNova)
SUNRISE, Fla., June 26 /PRNewswire/ -- Bioheart, Inc. announced today that in conjunction with Cleveland Clinic it will receive funds from a grant awarded by the Biomedical Research and Commercialization Program (BRCP) of the State of Ohio.